MedTrace Logo

Observational Follow-up Study of REGATTA

NCT03176563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 398

Last updated 2019-11-27

No results posted yet for this study

Summary

Observational follow-up study of patients included in the clinical trial REGATTA.

Conditions

Interventions

DRUG

Arctuvan

application of a herbal drug in the clinical trial REGATTA (NCT03151603)

DRUG

Placebo to Fosfomycin

application of Placebo to Fosfomycin in the clinical trial REGATTA (NCT03151603)

DRUG

Fosfomycin

application of an antibiotic drug in the clinical trial REGATTA (NCT03151603)

DRUG

Placebo to Arctuvan

application of Placebo to Arctuvan in the clinical trial REGATTA (NCT03151603)

Sponsors & Collaborators

  • University Medical Center Goettingen

    lead OTHER

Principal Investigators

  • Eva Hummers-Pradier, Prof. Dr. · University Medical Center Göttingen

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-03
Primary Completion
2019-07-19
Completion
2019-08-20

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03176563 on ClinicalTrials.gov